First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever

被引：8

作者：

Menard, Amelie ^{[1
]}

Colson, Philippe ^{[2
,3
]}

Catherine, Dhiver ^{[1
]}

Isabelle, Ravaux ^{[1
]}

Christelle, Tomei ^{[1
]}

Meddeb, Line ^{[1
]}

Ben Ali, Souad ^{[4
]}

Solas, Caroline ^{[5
]}

Stein, Andreas ^{[1
,2
]}

机构：

[1] Fdn Inst Hosp Univ IHU Mediterranee Infect, Serv Malad Infect, Pole Malad Infect & Tropicales Clin & Biol, F-13005 Marseille, France

[2] Aix Marseille Univ, CNRS, Inserm 1095, URMITE,UM63,IRD 198, F-13005 Marseille, France

[3] Fdn IHU Mediterranee Infect, Pole Malad Infect & Tropicales Clin & Biol Federa, F-13385 Marseille 05, France

[4] Aix Marseille Univ, INSERM, Ctr Hosp Univ Timone,AP HM, Serv Hepatogastroenterol,UMR CR02 911, 264 Rue St Pierre, F-13385 Marseille 05, France

[5] Aix Marseille Univ, INSERM, Ctr Hosp Univ Timone,AP HM,UMR CR02 911, Fac Pharm,Lab Pharmacocinet & Toxicol, 264 Rue St Pierre, F-13385 Marseille 05, France

来源：

CLINICAL INFECTIOUS DISEASES | 2016年 / 62卷 / 07期

关键词：

D O I：

10.1093/cid/civ1215

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：3

共 50 条

[1] First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever Reply
Shafran, Stephen D.
CLINICAL INFECTIOUS DISEASES, 2016, 62 (07) : 949 - +
[2] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
Dold, L.
Schwarze-Zander, C.
Boesecke, C.
Mohr, R.
Langhans, B.
Wasmuth, J-C
Strassburg, C. P.
Rockstroh, J. K.
Spengler, U.
SCIENTIFIC REPORTS, 2019, 9 (1)
[3] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
L. Dold
C. Schwarze-Zander
C. Boesecke
R. Mohr
B. Langhans
J.-C. Wasmuth
C. P. Strassburg
J. K. Rockstroh
U. Spengler
Scientific Reports, 9
[4] Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Bruno, Giuseppe
Saracino, Annalisa
CURRENT HIV RESEARCH, 2017, 15 (06) : 422 - 433
[5] Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals
Hasson, Hamid
Merli, Marco
Messina, Emanuela
Bhoori, Sherrie
Salpietro, Stefania
Morsica, Giulia
Regalia, Enrico
Bagaglio, Sabrina
Lazzarin, Adriano
Uberti-Foppa, Caterina
Mazzaferro, Vincenzo
JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 415 - 417
[6] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
Carrasco, Itziar
Sainz, Talia
Antoinette Frick, Marie
Jimenez de Ory, Santiago
Fortuny, Claudia
Burgos, Joaquin
Montero, Marta
Gavilan, Cesar
Dolores Falcon, Maria
Antonio Couceiro, Jose
Ignacio Bernardino, Jose
Bisbal, Otilia
Guerrero, Carmelo
Teresa Aldamiz-Echevarria, Maria
Berenguer, Juan
Luisa Navarro, Maria
JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
[7] Lipid Profiles After Therapy with Direct-Acting Antivirals in HCV Mono-infected and HCV/HIV Co-infected Patients
Simmons, Okeefe L.
Drechsler, Henning
Kouma, Marcus
Brown, Geri
Bedimo, Roger
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S343 - S343
[8] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
Rockstroh, Juergen K.
LIVER INTERNATIONAL, 2015, 35 : 51 - 55
[9] Liver fibrosis evolution after hepatitis C treatment with direct acting antivirals (DAA) in co-infected patients HCV/HIV
Mendez, J.
Videira Santos, F.
Cipriano, A.
Soeiro, C.
Valdoleiros, S.
Goncalves, C.
Tavares, A. P.
Castro, R. Sarmento E.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 241 - 241
[10] Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals
Rossotti, Roberto
Merli, Marco
Baiguera, Chiara
Bana, Nicholas Brian
Rezzonico, Leonardo Francesco
D'Amico, Federico
Raimondi, Alessandro
Moioli, Maria Cristina
Chianura, Leonardo Gerolamo
Puoti, Massimo
JOURNAL OF VIRAL HEPATITIS, 2023, 30 (06) : 530 - 539

← 1 2 3 4 5 →